Lawton Vincent Michael recorded the disposal and award of 2,507,487 Addex Therapeutics shares on Sept. 2, 2026. The related records show ownership of 2,507,987 shares after the award and 500 shares after the disposal, while derivative securities ended at 501,598, giving investors the disclosed post-transaction holdings.

Key Highlights

  • The director’s derivative-security transactions each involved 501,598 derivative securities on Sept. 2, 2026.
  • Ownership after the share award was reported at 2,507,987 Addex Therapeutics shares.
  • The disposal record showed 500 shares remaining afterward.

Lawton Vincent Michael disposed of 2,507,487 Addex Therapeutics Ltd. shares on Sept. 2, 2026, while a same-day award covered 2,507,487 shares. The transactions were recorded by Michael, a director of Addex Therapeutics Ltd. The filing reported separate post-transaction ownership figures for the two share entries. Following the disposal, Michael was shown as owning 500 shares. Following the award, his reported share ownership was 2,507,987 shares. The records describe both actions on the same date, with each tied to its own subsequent ownership figure.

501,598 Derivative Securities Recorded

Michael also disposed of 501,598 Addex Therapeutics Ltd. derivative securities on Sept. 2, 2026. A separate award on that date covered 501,598 derivative securities. The post-transaction ownership associated with the disposal was zero derivative securities, while the award record showed ownership of 501,598 derivative securities.